Predictive Biosciences To Present Novel Combination Approach To Molecular Cancer Diagnostics At 2010 Genitourinary Cancers Symposium
March 8, 2010 – 5:21 amPredictive Biosciences announced that the Company will be presenting its novel Multi-Analyte Diagnostic Readout (MADR™) approach to the development of a non-invasive, urinary biomarker based assay for the detection of bladder cancer during the 2010 Genitourinary Cancers Symposium (GU Symposium), being held March 5-7 in San Francisco. The GU Symposium is co-sponsored by the American Society of Clinical Oncology (ASCO), the American Society for Radiation Oncology (ASTRO) and the Society of Urologic Oncology (SUO)…
Related Info :
Tags: 2010, American Society Of Clinical Oncology, Approach, Astro, Biosciences, Bladder Cancer, cancer, Cancer Diagnostics, Cancers, Combination, Combination Approach, Diagnostics, Genitourinary, Genitourinary Cancers, Molecular, Molecular Cancer, Novel, Novel Combination, Oncology, Predictive, Predictive Biosciences, Present, Radiation Oncology, San Francisco, Society Of Urologic Oncology, Symposium
